EDC, ePRO, eConsent

1. Is Your CRO’s 2023 Growth Limited By These Four Myths? 1/30/2023

   Learn how CROs can leverage eClinical technology to more effectively differentiate themselves in the crowded marketplace and provide sponsors with better clinical trial support.

2. Could ePRO Be The New Standard In Health Reimbursement? 1/30/2023

   Recently, early-phase protocols have been collecting patient-reported outcomes (PROs) not only to get regulatory approval but to demonstrate value to public and private payers.

3. Gain The ePRO Advantage With Real-time Data Collection 12/2/2022

   Discover how ePRO automatically incorporates eCOA data into a study, improving the depth, timeliness, and accuracy of patient-reported outcomes data in the following ways.

4. How To Overcome The Problem Of The Early ePRO Oversell 11/14/2022

   In this blog, explore how the approach to PROs needs to be reconsidered, given increasing regulations and trial scrutiny, the clinical need for patient-reported outcomes, and the ability to drive costs down and move off paper.

5. Start With ‘Why’ When Adopting New Tech To Support Hybrid Decentralized Trials 10/11/2022

   In this article, focus on the adoption of new clinical trial technology and explore how sponsors can support sites as they select and implement technologies.

6. Notes From The Field: How eConsent Improves Clinical Trials 10/3/2022

   The benefits of eConsent are multi-faceted. In this blog post, explore these advantages as they relate to participants, sites and sponsors/CROs.

7. Need Better Clinical Trial Retention? Start With eConsent 9/26/2022

   When participant retention is not addressed, learn how studies need to recruit additional participants and extend trial timelines, leading ultimately to budget overruns. 

8. Better eConsent Through Education Best Practices 9/23/2022

   eConsent can have a positive impact on participant retention, but learn why that is only part of the challenge of meeting participant needs in a clinical trial.